Janssen combines Darzalex with COVID-19 drug in new multiple myeloma submission

Janssen combines Darzalex with COVID-19 drug in new multiple myeloma submission

Source: 
Pharmaforum
snippet: 

Janssen has submitted a new combination regimen for its blockbuster multiple myeloma drug Darzalex for approval with the FDA and EMA, hoping to give the treatment another edge over emerging competitors.